- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ACCC Publication Offers Insight for Incorporating Immunotherapies Into Practice
The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties.
The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties. Targeted materials developed by the institute include a how-to guide for developing an interdisciplinary toxicity team to help manage immune-related adverse events, as well as workshops and webinars focused on effective practices for multidisciplinary teams delivering these new therapies.
See more highlights from the report.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
